This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Ding-Ming Shen
Introduction
Ding-Ming Shen is an accomplished inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body.
Latest Patents
Ding-Ming Shen holds a patent for "Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists." This invention provides compounds of Formula (I), pharmaceutical compositions thereof, and methods of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. His innovative work in this area showcases his expertise in medicinal chemistry and pharmacology.
Career Highlights
Ding-Ming Shen is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck allows him to contribute to the development of new therapeutic solutions that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Richard Berger and Lehua Chang. Their collaborative efforts in research and development have further advanced the projects they are involved in.
Conclusion
Ding-Ming Shen's contributions to the field of pharmaceuticals through his innovative patents and work at Merck Sharp & Dohme Corporation highlight his importance as an inventor. His dedication to advancing medical science continues to make a positive impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile